Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Southern Medical University, Guangzhou 510515, China.
Biochem Biophys Res Commun. 2018 May 5;499(2):345-353. doi: 10.1016/j.bbrc.2018.03.161. Epub 2018 Mar 26.
Hypertonic saline (HS) has been used clinically for treatment of cerebral edema for decades. Previously we have demonstrated that HS alleviates cerebral edema via regulating water/ion channel protein and attenuating neuroinflammation. However, whether HS treatment triggers microglia polarization and its regulatory mechanism during this process is unclear.
The Sprague-Dawley (SD) rats that underwent right-sided middle cerebral artery occlusion (MCAO) were used for assessment of neuroinflammation and microglia functions. Treatment of 10% HS not only significantly reduced infarct size and ipsilateral ischemic hemispheric brain water content (BWC) via attenuating ischemia-induction of TNF-α, IL-1β, microglia M1 markers (iNOS, CD86) and miR-200b, but also increased neurotrophic factors such as IL-10 and IL-4, microglia M2 markers (Arg1, CD206) and Krüppel-like factor 4 (KLF4). Similar changes were confirmed in primary microglial cells subjected to hypoxia with/without HS in vitro. Importantly, overexpression of miR-200b was able to induce microglia M1 polarization via directly targeting KLF4. Restoring KLF4 expression abolished this effect. On the contrary, miR-200b inhibitor or KLF4 overexpression led to microglia M2 polarization. Mechanistically, KLF4 directly binds to promoter region of Agr1, thus inducing its transcription. Similar to treatment of HS, experimental overexpression of KLF4 in vivo exerted significant beneficial effects on ischemia-induced cerebral edema. However, knockdown of KLF4 abrogated the benefits of HS.
Hypertonic saline regulates microglial M2 polarization via miR-200b/KLF4 during its treatment of cerebral edema. This study may provide new insights of HS-related therapy for cerebral edema.
高渗盐水(HS)已在临床上用于治疗脑水肿数十年。此前,我们已经证明 HS 通过调节水/离子通道蛋白和减轻神经炎症来减轻脑水肿。然而,HS 治疗在此过程中是否会引发小胶质细胞极化及其调节机制尚不清楚。
使用 Sprague-Dawley(SD)大鼠进行右侧大脑中动脉闭塞(MCAO)评估神经炎症和小胶质细胞功能。10%HS 的治疗不仅通过减轻 TNF-α、IL-1β、小胶质细胞 M1 标志物(iNOS、CD86)和 miR-200b 的缺血诱导,显著降低了梗死面积和同侧缺血半球脑水含量(BWC),而且还增加了神经营养因子,如 IL-10 和 IL-4、小胶质细胞 M2 标志物(Arg1、CD206)和 Krüppel 样因子 4(KLF4)。在体外缺氧的原代小胶质细胞中也证实了类似的变化,有/没有 HS。重要的是,miR-200b 的过表达能够通过直接靶向 KLF4 诱导小胶质细胞 M1 极化。恢复 KLF4 表达可消除这种作用。相反,miR-200b 抑制剂或 KLF4 过表达导致小胶质细胞 M2 极化。从机制上讲,KLF4 直接结合 Agr1 的启动子区域,从而诱导其转录。类似于 HS 的治疗,体内过表达 KLF4 对缺血诱导的脑水肿有显著的有益作用。然而,KLF4 的敲低削弱了 HS 的益处。
高渗盐水通过 miR-200b/KLF4 在治疗脑水肿过程中调节小胶质细胞 M2 极化。这项研究可能为 HS 相关治疗脑水肿提供新的见解。